Test Price
3,000 AED✅ Home Collection Available
Chromosomal Microarray 60K with Karyotyping Test in UAE | 3000 AED | 2026 DHA Guidelines
تحليل ميكروأري 60 ألف مع التنميط النووي في الإمارات | 3000 درهم | معتمد من هيئة الصحة بدبي
Clinical & Operational Guarantee
- Accuracy: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Microarray (Agilent) & Karyotyping.
- Premium Logistics: Paid Hospital‑Grade Home Collection with ISO‑Certified Cold‑Chain Transport; VIP Mobile Phlebotomy service 8 AM‑11 PM daily.
- Clinical Guidance: Complimentary telephonic post‑test result interpretation by a DHA‑licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 (all major UAE networks).
دقة تشخيصية تصل إلى 99.9% مع خدمة سحب الدم المنزلي المدفوعة بمعايير ISO المعتمدة، ونقل العينات عبر سلسلة تبريد موثقة، وإرشاد طبي هاتفي بعد ظهور النتيجة.
Comprehensive Genomic Profiling – Why This Test Matters
The Chromosomal Microarray 60K with Karyotyping (Peripheral Blood / Cord Blood / Fetal Blood) integrates high‑resolution copy‑number variation (CNV) detection via Agilent 60K microarray with standard G‑banded karyotyping. This dual approach identifies submicroscopic deletions, duplications, and large chromosomal anomalies in one definitive workflow – essential for paediatric developmental delay, prenatal diagnosis, recurrent pregnancy loss, and haematological malignancy screening.
يجمع الاختبار بين تقنية الميكروأري 60 ألف عالي الدقة والتنميط النووي التقليدي لتحديد التغيرات الكروموسومية الدقيقة والكبرى بدقة تشخيصية متكاملة.
| Feature | Our Microarray 60K + Karyotype | Conventional Karyotype Alone |
|---|---|---|
| Resolution | ~60 kb CNV detection genome‑wide (Agilent) | 5‑10 Mb (visible bands only) |
| Methodology | Agilent 60K Array + Cell Culture Karyotyping | GTG Banding alone |
| Turnaround Time | 7‑9 working days | 10‑14 days |
| Clinical Utility | Pathogenic CNVs + aneuploidy + balanced rearrangements | Aneuploidy & large structural anomalies only |
Physician Insight & Safety Protocol
“As a clinical cytogeneticist, I emphasise that while this integrated genomic test provides high sensitivity for chromosomal aberrations, every result must be interpreted within the full clinical picture. Variants of uncertain significance are common – correlation with phenotype, family studies, and specialised genetic counselling is essential to avoid unnecessary anxiety or misdirected intervention.”
— Dr. Prabhakar Reddy, DHA License: 61713011
⚠️ Medication Advisory:
Do not discontinue any prescribed medication or modify treatment plans without consulting your supervising physician. Genetic test results alone do not replace clinical judgement.
Patient Exclusion Criteria & Red Flags
- Active systemic infection (fever >38.5°C) – reschedule collection until afebrile for 24 hours.
- Current anticoagulant therapy at therapeutic doses (INR >3.0) without prior medical clearance.
- Known haemoglobin <7 g/dL – venepuncture risk must be assessed.
- Recent (<4 weeks) bone marrow transplant or blood product transfusion may yield non‑constitutional results.
- Emergency warning: If the patient experiences acute bleeding, sudden severe headache, chest pain, or loss of consciousness after sample collection, proceed to the nearest emergency department immediately.
Frequently Asked Questions (Patient‑Centred Guidance)
1. What conditions can Chromosomal Microarray 60K with Karyotyping detect that a routine karyotype might miss?
Chromosomal microarray (CMA) at 60‑kilobase resolution detects submicroscopic deletions and duplications known as copy‑number variants (CNVs) that are invisible on a standard karyotype, making it essential for diagnosing microdeletion syndromes like 22q11.2 or 16p11.2, autistic spectrum‑related CNVs, and unexplained intellectual disability, while the included karyotype confirms balanced translocations and large aneuploidies.
يكشف الميكروأري 60 ألف عن الحذف والازدواج الجيني الدقيق الذي لا يظهر في التنميط النووي التقليدي، مما يجعله ضرورياً لتشخيص متلازمات مثل حذف 22q11.2 والاضطرابات النمائية غير المفسَّرة.
2. Can this test be performed on cord blood or fetal blood, and what are the requirements?
Yes, the accepts cord blood or fetal blood samples obtained via cordocentesis under strict aseptic conditions; a consultant obstetrician must provide a clinical justification, and the sample must be transported in a sodium‑heparin tube via our ISO‑certified cold chain to preserve cellular viability for culture.
نعم، يُقبل دم الحبل السري ودم الجنين بعد تبرير سريري من استشاري التوليد، مع النقل في سلسلة تبريد معتمدة للحفاظ على حيوية الخلايا للزرع المختبري.
3. How do I prepare for the home blood collection and will insurance cover the cost?
For a standard peripheral blood draw, remain hydrated and wear loose clothing; our DHA‑licensed mobile phlebotomist arrives with pre‑cooled transport kit, and we instantly verify your insurance eligibility via WhatsApp at +971 54 548 8731 – most major policies cover medically indicated genetic testing with a doctor’s prescription.
يصل أخصائي السحب المرخص من هيئة الصحة إلى منزلك مع أدوات النقل المبرَّدة، ونتحقق فوراً من تغطية التأمين عبر واتساب بعد تقديم الوصفة الطبية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians